Niacin increases atherogenic proteins in HDL of statin-treated subjects

OBJECTIVE –: Niacin therapy fails to reduce cardiovascular events in statin-treated subjects even though it increases plasma HDL cholesterol (HDL-C) and decreases LDL-C and triglyceride levels. To investigate potential mechanisms for this lack of cardioprotection, we quantified the HDL proteome of s...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Arterioscler Thromb Vasc Biol
Asıl Yazarlar: Ronsein, Graziella E., Vaisar, Tomas, Davidson, W. Sean, Bornfeldt, Karin E., Probstfield, Jeffrey L., O’Brien, Kevin D., Zhao, Xue-Qiao, Heinecke, Jay W.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2021
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8295224/
https://ncbi.nlm.nih.gov/pubmed/34134520
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/ATVBAHA.121.316278
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller